HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
OEI Partnership Opportunities
The Office of Entrepreneurship & Innovation (OEI) partners with internal CHOP innovators, industry, investors, and entrepreneurs to bring ideas to life.
Our team collaborates with employees from all CHOP research divisions and areas of the organization, regardless of project stage and business background. If you have innovative research or a solution with the potential to impact pediatric healthcare through commercialization, OEI can help you advance your work.
If your idea needs additional funding or development to move toward commercialization, Innovation [at] chop.edu (contact us)title="Contact OEI" to learn more or submit an idea using our internal project intake form.
The Office of Entrepreneurship & Innovation continues to create a robust portfolio of innovative projects, including new drug targets, therapeutic platforms, medical devices, digital health and software solutions, or other projects that have high impact potential and are commercially attractive. We are actively developing partnerships with industry to advance our work to various commercial endpoints so it can make the greatest impact on children.
If you are interested in partnering with OEI or our innovators, Innovation [at] chop.edu (contact us)title="Contact OEI".
The Office of Entrepreneurship & Innovation is seeking greater engagement in the regional and national venture community. If you are an investment professional or entrepreneur and would like to collaborate with OEI or our innovators, or learn more about our projects, Innovation [at] chop.edu (contact us)title="Contact OEI".
Work With Us
As an innovator, inventor, researcher, or entrepreneur at CHOP, you are uniquely positioned to leverage OEI to accelerate your idea forward and enhance our ability to care for patients. Our process is designed to help develop your innovative solution or research from discovery to commercialization.
OEI accepts innovative projects and research at any stage of project development, and will support any CHOP faculty or staff, regardless of their background or role in the organization. The OEI team prepares CHOP employees to innovate and advance their ideas or research toward commercial endpoints, which could be a licensing deal with an industry partner or the formation of a new company.
The evaluation phase is the first formal step in our project development process. An OEI project manager will guide the project throughout the entire process and will enter the project and team into our master project database. In collaboration with the Office of Technology Transfer (OTT), we will formally evaluate the project for commercial potential. This includes the development of a target product profile, market research and regulatory pathway strategy, an IP assessment, a potential budgeting and cost of goods assessment, and more.
In the development phase, a formal project team will develop a high-level business plan, detailed project plan, list of resources, and timeline to reach future milestones. Pre-defined go/no-go criteria will be established for each sub-phase in the development phase. These go/no-go criteria and the learnings in this phase will support ongoing evaluations and recommendations related to project continuation, future milestones, or decision points.
Depending on the source of a project, the OEI project manager may work closely with specific CHOP teams or other internal or external partners as appropriate.
The development phase timeline varies with each project. A particular project may require several iterations and funding cycles dependent on various factors to move toward a commercial exit from CHOP.
The exit phase of a project refers to its conclusion due to a successful licensing deal with an industry partner or the formation of a new company.
Commercial potential will be continually evaluated throughout the exit phase as market dynamics evolve and technology potential is better understood. OTT is represented on every project team and works closely with OEI project managers to support the intellectual property and commercialization strategies. Similarly, OEI is active and in regular contact with our venture capital network and industry relationships to "shop" our emerging pipeline around.
The continuum between OEI and OTT to optimize an asset for eventual exit is designed to be integrated and seamless, and establishing a successful exit ultimately resides with the Office of Technology Transfer.